Table 2.

Univariate and Multivariate GLM Regression Analysis Investigating Association with 90-Day mortality

Characteristics	Univariate analysis			Multivariate analysis
	Odds Ratio (95% CI)	P-value		Odds Ratio (95% CI)	P-value
NRBC, %	1.412 (1.154–1.727)	< 0.001		1.282 (1.020–1.611)	0.033
Sex (Female vs. Male)	0.803 (0.516–1.249)	0.330
Race (While vs. Non-while)	1.042 (0.665–1.634)	0.857
Age (< 60 vs. ≥60)	2.805 (1.783–4.411)	< 0.001		2.038 (1.172–3.541)	0.012
CHF (No vs. Yes)	2.107 (1.296–3.424)	0.003		1.743 (0.963–3.155)	0.066
CPD (No vs. Yes)	1.286 (0.747–2.212)	0.364
Diabetes (No vs. Yes)	1.099 (0.677–1.783)	0.703
Renal disease (No vs. Yes)	2.019 (1.183–3.446)	0.010		1.057 (0.561–1.993)	0.864
Cerebrovascular disease (No vs. Yes)	0.670 (0.289–1.553)	0.350
Vasopressin (No vs. Yes)	3.406 (2.134–5.437)	< 0.001		1.792 (0.947–3.391)	0.073
Norepinephrine (No vs. Yes)	2.809 (1.772–4.453)	< 0.001		1.528 (0.778–3.001)	0.218
RRT (No vs. Yes)	1.380 (0.636–2.991)	0.415
SOFA	1.096 (1.044–1.150)	< 0.001		0.983 (0.887–1.089)	0.739
SAPSII	1.044 (1.028–1.061)	< 0.001		1.027 (1.001–1.053)	0.043
OASIS	1.042 (1.019–1.067)	< 0.001		0.979 (0.941–1.018)	0.280
LODS	1.129 (1.064–1.199)	< 0.001		0.968 (0.844–1.110)	0.640
APSIII	1.019 (1.011–1.027)	< 0.001		1.011 (0.993–1.028)	0.229
GCS	0.980 (0.930–1.032)	0.442
MAP, mmHg	0.991 (0.984–0.998)	0.015		0.994 (0.987–1.002)	0.160

Abbreviations: APS III, Acute Physiology Score III; CHF, Congestive Heart Failure; CPD, Chronic Pulmonary Disease; GCS, Glasgow Coma Scale; GLM, generalized linear model; LODS, Logistic Organ Dysfunction System; MAP, Mean Arterial Pressure; NRBC, Nucleated Red blood Cells; OASIS, Oxford Acute Severity of Illness Score; RRT, renal replacement therapy; SAPS II, Simplified Acute Physiology Score II; SOFA, Sequential Organ Failure Assessment